Correlation Between AC Immune and Tempest Therapeutics

Can any of the company-specific risk be diversified away by investing in both AC Immune and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AC Immune and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AC Immune and Tempest Therapeutics, you can compare the effects of market volatilities on AC Immune and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AC Immune with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AC Immune and Tempest Therapeutics.

Diversification Opportunities for AC Immune and Tempest Therapeutics

0.56

Correlation Coefficient

AC Immune  Tempest Therapeutics

Very weak diversification

The 3 months correlation between ACIU and Tempest is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding AC Immune and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and AC Immune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AC Immune are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of AC Immune i.e., AC Immune and Tempest Therapeutics go up and down completely randomly.

Pair Corralation between AC Immune and Tempest Therapeutics

Given the investment horizon of 90 days AC Immune is expected to under-perform the Tempest Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, AC Immune is 1.13 times less risky than Tempest Therapeutics. The stock trades about -0.15 of its potential returns per unit of risk. The Tempest Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  84.00  in Tempest Therapeutics on December 28, 2024 and sell it today you would lose (6.79) from holding Tempest Therapeutics or give up 8.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

AC Immune  vs.  Tempest Therapeutics

AC Immune

Risk-Adjusted Performance

Very Weak

Over the last 90 days AC Immune has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Tempest Therapeutics

Risk-Adjusted Performance

Weak

Over the last 90 days Tempest Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Tempest Therapeutics is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with AC Immune and Tempest Therapeutics

The main advantage of trading using opposite AC Immune and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AC Immune position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.

The idea behind AC Immune and Tempest Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.